Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Garrett Motion Inc. Common Stock (GTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Garrett Motion Inc. Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.45 (market cap $4.59B), while Garrett Motion Inc. Common Stock trades at $25.9 (market cap $4.80B). The key difference: Definium Therapeutics Inc. Common Shares and Garrett Motion Inc. Common Stock are close in size by market cap, and Garrett Motion Inc. Common Stock pays a 1.24% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Garrett Motion Inc. Common Stock for 0 Days on average.
| DFTX | GTX | |
|---|---|---|
Market Cap | $4.59B | $4.80B |
Volume | 2,103,937 | 2,132,039 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.45 | $36.23 |
52-Week Low | $10.68 | $12.49 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.55B | $6.06B |
Dividend Yield | — | 1.24% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Garrett Motion Inc. Common Stock
Garrett Motion develops turbocharging and air-boosting technologies for vehicles. Its products are used in internal combustion, hybrid, and other vehicle powertrains.
Read more on GTX →
